Spark2Flame, Inc
Biotech
Maternal antibody biomarkers and decoy antigen therapeutics to prevent autism spectrum disorder
- Grants
- $2.0M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Autism Spectrum Disorder Diagnostic/Therapeutic Agent | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Autism Spectrum Disorder Diagnostic/Therapeutic Agent | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A diagnostic for maternal autoAb to Caspr2 to predict increased risk of autism spectrum disorder in children | $220,393 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing a prenatal biologic therapy to mitigate ASD risk from maternal autoantibodies to Caspr2 | $677,502 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing a prenatal biologic therapy to mitigate ASD risk from maternal autoantibodies to Caspr2 | $677,986 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2444 | INTERVAL THERAPEUTICS LLC | — | — |
| 2445 | PAZ PHARMACEUTICALS | — | — |
| 2446 | Ribometrix LLC | — | $18M |
| 2447 | Spark2Flame, Inc | — | — |
| 2448 | Biohaven Pharmaceutical Holding Co Ltd. | — | $40M |
| 2449 | Ionetix Corp | — | $38M |
| 2450 | CALISTOGA PHARMACEUTICALS INC | — | $35M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.